NEW YORK (GenomeWeb) – Natera said today that it is ending its distribution agreement with Bio-Reference Laboratories, and plans instead to promote its Panorama noninvasive prenatal test and Horizon carrier screening test directly to clinicians.
...and receive Daily News bulletins.
Already have an account?Login Now.
This webinar offers a look at how an advanced genetics laboratory implemented and validated a commercial bioinformatics system to help scale its operations.
Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.
In this webinar, Kevin Balbi, head of bioinformatics at Sarah Cannon Molecular Diagnostics, will discuss the validation of targeted sequencing panels on the Ion Torrent platform using Horizon Discovery’s Tru-Q controls.